Table 1.
Description of study contexts
| Study abbreviation and country | Region (location) | Study dates | Endemicity setting (mRDT positivity) | Number (%) of patients with a positive mRDT result that are under 5 years† | Health care sector | ||
|---|---|---|---|---|---|---|---|
| Number (%) of patients with a positive mRDT result of those tested with mRDT | Category | ||||||
| Cam1 [20] | Cameroon | West Cameroon (Bamenda) | October–December 2011 | 124/598 (20.7) | Mod–low | 34/124 (27.4) | Public/mission |
| Central Cameroon (Yaoundé) | 145/390 (37.2) | Mod–low | 62/145 (42.8) | ||||
| Ghan1 [21] | Ghana | Southeast Ghana (Dangme West) | August 2007–December 2008 | 1308/3631 (36.0) | Mod–low | 407/1308 (31.1) | Public |
| Nige1 [24] | Nigeria | South central Nigeria (Udi) | July–December 2009; June–December 2011 | 139/323 (43.0) | Mod–high | 16/137 (11.7) | Public and private retail |
| South central Nigeria (Enugu) | 442/788 (56.1) | High | 28/434 (6.5) | ||||
| Tanz1 [23] | Tanzania | West Tanzania (Mbeya) | May–October 2010; April–July 2012 | 18/128 (14.1) | Low | 9/18 (50.0) | Public |
| North Tanzania (Mwanza) | 46/278 (16.6) | Low | 34/46 (73.9) | ||||
| Southeast Tanzania (Mtwara) | 173/367 (47.1) | Mod–high | 110/173 (63.6) | ||||
| Tanz2 [22] | Tanzania | Northeast Tanzania (Kilimanjaro) | September 2010–January 2011 | 295/4334 (6.8) | Low | 51/294 (17.3) | Public |
| Northeast Tanzania (Tanga) | February 2011–March 2012 | 4105/12,963 (31.7) | Mod–low | 1429/4102 (34.8) | |||
| Uga1 [25] | Uganda | Southeast Uganda (Tororo) | April 2011–March 2013 | 90,269/132,241 (68.3) | High | 37,339/88,875 (42.0) | Public |
| Uga2 [26] | Uganda | Southwest Uganda (Nyakishenyi) | January–December 2011 | 37/1128 (3.3) | Low | 4/35 (11.4)* | Community health worker |
| Southwest Uganda (Bwambara) | 3411/7632 (44.7) | Mod–high | 238/3342 (7.1)* | ||||
| Uga3 [27] | Uganda | South central Uganda (Mukono) | January–December 2011 | 5690/9987 (57.0) | High | 2239/5597 (40.0) | Private retail |
*Uga2 included only patients aged < 6 years; proportions presented for patients aged < 1 year
†Denominators vary to reported number testing positive by mRDT due to missing data for age. Nige1 (Udi: n = 2; Enugu: n = 8), Tanz2 (Kilimanjaro: n = 1; Tanga: n = 3), Uga1 (n = 1394), Uga2 (Bwambara: n = 22), Uga3 (n = 28)